Avacta Group plc, the developer of Affimer ® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global ...
IRVINE, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today they have submitted to the FDA an EUA application for an ELISA lab-based serology blood test for the ...
SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international healthcare solutions company targeting oncological ...
New Delhi, May 22 (IANS) In a first of its kind technology, a test would now help rapid and accurate estimation of total antibody concentration of Covid-19 in clinical samples. The novelty of the ...
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "ELISA Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The ...
Enzyme-linked immunosorbent assays (ELISAs) represent the gold standard for quantitatively detecting protein biomarkers, and are used for applications such as diagnosing or monitoring disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results